The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period.

Source:http://linkedlifedata.com/resource/pubmed/id/20184783

Download in:

View as

General Info

PMID
20184783